Article Versions Notes

Gerov V, Gerova D, Micheva I, Nikolova M, Pasheva M, Nazifova N, Galunska B. Circulating sRANKL, Periostin, and Osteopontin as Biomarkers for the Assessment of Activated Osteoclastogenesis in Myeloma Related Bone Disease. Cancers. 2023; 15(23):5562. https://doi.org/10.3390/cancers15235562

Gerov, Vladimir, Daniela Gerova, Ilina Micheva, Miglena Nikolova, Milena Pasheva, Neshe Nazifova, and Bistra Galunska. 2023. "Circulating sRANKL, Periostin, and Osteopontin as Biomarkers for the Assessment of Activated Osteoclastogenesis in Myeloma Related Bone Disease" Cancers 15, no. 23: 5562. https://doi.org/10.3390/cancers15235562

Gerov, V., Gerova, D., Micheva, I., Nikolova, M., Pasheva, M., Nazifova, N., & Galunska, B. (2023). Circulating sRANKL, Periostin, and Osteopontin as Biomarkers for the Assessment of Activated Osteoclastogenesis in Myeloma Related Bone Disease. Cancers, 15(23), 5562. https://doi.org/10.3390/cancers15235562